Skip to content

Clinical trials

Phase 4 Hematologic Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Phase: Phase 4 Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20051
20081
20091
20122
20131
20141
20151
20162
20171
20181
20191
20201
20212
20222
20231
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Unknown status4
Active, not recruiting2
Terminated2
Recruiting2
Not yet recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center4
Shandong Provincial Hospital2
Abramson Cancer Center at Penn Medicine1
Amsterdam UMC, location VUmc1
Centre Hospitalier Régional d'Orléans1
Eli Lilly and Company1
H. Lee Moffitt Cancer Center and Research Institute1
Hamad Medical Corporation1
Hospital Clinic of Barcelona1
Hospital Universitari Vall d'Hebron Research Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms24
Febrile Neutropenia3
Neoplasms3
Invasive Fungal Infections2
Lymphoma2
Mycoses2
Neoplasms, Plasma Cell2
Neutropenia2
Acquired Immunodeficiency Syndrome1
Bacteremia1

Trials

Showing 26 to 24 of 24. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.